PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 218 results · Oncology  · Clear
🔒 Subscribers only
AUTH/3405/10/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
LEO
An anonymous complainant (described as a pharmaceutical physician) complained about 60 videos featuring UK health professionals and/or UK patients on the LEO Pharma Global YouTube channel. The Case…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3411/10/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Daiichi Sankyo & AstraZeneca
A UK health professional complained about a Daiichi-Sankyo Inc LinkedIn post announcing initiation of the DESTINY-Breast05 Phase 3 trial for HER2+ early breast cancer, linking to a press release ab…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3295/1/20
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca & Merck Sharp &
An anonymous practising oncologist complained about a jointly organised advisory board in London (8 Nov 2019) on new ovarian cancer data (PAOLA-1 and PRIMA) relating to Lynparza (olaparib).The comp…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3362/6/20
Patient Organisations Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
Roche voluntarily admitted that a promotional email for Tecentriq (atezolizumab) was inadvertently sent by a third-party agency to members of the public.The email was intended for UK oncologists an…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3320/3/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Takeda breached ABPI Code over unclear differentiation between Prostap SR DCS and Prostap 3 DCS indi
A UK health professional complained about Takeda promotional material for Prostap (leuprorelin acetate) hosted on the Guidelines in Practice website.The materials included a “Formulary Decision G…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3167/2/19
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis retweet about haematology masterclass
A UK health professional complained about Novartis UK retweeting (without added comment) a clinician’s tweet praising talks at the “@NovartisUK Haematology Masterclass” and listing disease ar…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3286/12/19
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bristol-Myers Squibb
During responses to an earlier case (AUTH/3241/8/19) about incorrect overall survival data in a Urology News promotional article for Opdivo (nivolumab) and Yervoy (ipilimumab), Bristol-Myers Squibb…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3158/2/19
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Servier advisory board (Lonsurf)
A Servier employee complained about a metastatic colorectal cancer (mCRC) advisory board held on 23 June 2017 concerning Lonsurf (trifluridine/tipiracil). Allegations included that representative…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3241/8/19
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bristol-Myers Squibb Pharmaceuticals Limited — Opdivo (nivolumab); Yervoy (ipilimumab); comparator referenced: sunitinib (Sutent, marketed by Pfizer)
Bristol-Myers Squibb Pharmaceuticals Limited made a voluntary admission that overall survival (OS) results in a promotional article were incorrect.The material was published online and in the hard …
Clauses: 7.2,14.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3238/8/19
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Vifor corporate website
An anonymous, non-contactable individual describing themself as a “concerned UK health professional” complained about Vifor Pharma UK Limited’s corporate website pages for IV irons.The compla…
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3168/2/19
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen Medical Cloud website
A contactable individual describing themself as a concerned UK health professional complained about the Janssen Medical Cloud website, described on its homepage as for healthcare professionals and …
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3213/6/19
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen
An anonymous, non-contactable health professional complained about alleged off-licence promotion at a Janssen-sponsored oncology meeting (1–2 March 2019, London) titled “8th Prostate Cancer Sum…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3212/6/19
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Otsuka UK/Otsuka Europe
An anonymous health professional complained about an online press release on ASTX727 (cedazuridine/decitabine fixed-dose combination) relating to the phase III ASCERTAIN study.The press release was…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3256/10/19
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis breached ABPI Code over Kisqali leaflet
An anonymous health professional complained about a Novartis promotional leaflet for Kisqali (ribociclib succinate) (ref KIS19-CO25a), dated June 2019.The leaflet was placed in delegate bags at a b…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/1899/10/06
Samples & Gifts Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
What happened The MHRA forwarded a complaint from an ex-employee about representative call-frequency targets linked to promotion of Casodex (bicalutamide). Evidence included an AstraZeneca oncology…
Clauses: 15.4,15.9,9.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3292/12/19
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Employee complaint about ECR ‘round table’ dinner and compliance culture at GE Healthcare (No breach
A GE Healthcare employee complained about arrangements for an event described as an “Oncology CT Imaging Round Table” held on 27 February 2019 during the European Society of Radiology (ECR) con…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3230/7/19
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
GSK breach over Zejula pipeline tweet on public Twitter feed (AUTH/3230/7/19)
A ‘concerned UK health professional’ complained about a tweet on GlaxoSmithKline’s global corporate Twitter channel (@GSK) that appeared in their feed.The tweet was part of a linked Q2 2019 r…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3128/12/18
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen
An individual complained about a leaflet promoting Imbruvica (ibrutinib) on Janssen-Cilag’s exhibition stand at a UK Oncology Nurses Society meeting in Glasgow (November 2018).The leaflet (ref PH…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3031/4/18
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Gilead speaker training meeting
An anonymous health professional complained about a Gilead Oncology Faculty Meeting in Frankfurt (March 2018), described by Gilead as a speaker training meeting for Zydelig (idelalisib) in CLL/FL.T…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3012/1/18
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Pierre Fabre
Pierre Fabre made a voluntary admission of Code breaches relating to materials for Toviaz (fesoterodine) used at an April 2017 cycle meeting and then emailed to representatives (email dated 2 May 2…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3085/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Biogen
The PMCPA Director opened a complaint (under Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted results to the EU Clinical Trials Register (EUCTR) with…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3080/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Takeda
The PMCPA Director opened a complaint (under Paragraph 5.1 of the Constitution and Procedure) after a BMJ paper (Goldacre et al, published 12 Sept 2018) assessed whether sponsors posted due results…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3078/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Amgen
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3103/10/18
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Ipsen
An anonymous, non-contactable complainant alleged an Ipsen meeting about Cabometyx (cabozantinib) for advanced renal cell carcinoma (RCC) was a “glorified sales pitch”, biased, and scientifical…
Clauses: NONE
2018 🔒 Subscribe
← Prev 1 2 3 4 5 6 7 Next → Page 4 of 10 — 218 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews